Natoli Installs Tablet Press at its New Research and Training Facility

Publication
Article
In the Lab eNewsletterPharmaceutical Technology's In the Lab eNewsletter 10-07-2020
Volume 15
Issue 10

Natoli installed a NP-RD30 rotary tablet press for R&D at its new lab in Germany.

Natoli Engineering installed its Natoli NP-RD30 rotary tablet press in its new research and training facility, the Diosna ProcessLab in Osnabrück, Germany. The lab was completed in April 2020 and is built for research and formulation trials as well as virtual and in-person training classes. With the tablet press, the lab offers complete production of tablets from powder mixing, granulation, final blending, and tableting to coating.

The tablet press combines the design of a full-scale production press with the analytical capabilities of an R&D machine. Designed to tackle formulation and scale-up challenges, the tablet press comes equipped with a 21” HMI touchscreen, a USB port for data transfer, rolling casters, a dual vacuum system, a built-in calibration tool, upper and lower punch seals, powder recirculation system, and a self-adjusting lower punch with a push button feature, a Sept. 9, 2020 company press release said. The fast-fill cam design produces a vacuum to help with die filling for tablet weights while featuring diameter pre- and main compression rollers, independent overload, ejection, and take-off force monitoring.

Source: Natoli​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​

Articles in this issue
Restructuring Method Transfer Throughout Global Sites
Restructuring Method Transfer Throughout Global Sites
Darren Baker/Stock.Adobe.com - scientist observing test tube
When Assessing Protein Aggregation Grows Increasingly Challenging
Almac Sciences Adds Biologics Testing to its Analytical Solutions Suite
PharmaLex Group Completes Merger with BioStat Solutions
Natoli Installs Tablet Press at its New Research and Training Facility
Thermo Fisher to Invest More than $140 Million into its Lab Plastics Consumables for COVID-19 Testing
Sai Life Sciences’ Screening Capabilities Enhanced with Expanded Cellular Analysis Platforms
StarBright Violet 515 Dye from Bio-Rad Enhances Flow Cytometry
Paradigm4’s Single Cell App Allows for Analysis of Large-Scale Datasets
CytoSMART Technologies’ New Automated Live-Cell Imaging System Keeps Lab Teams Coordinated
Promega’s New Capillary Electrophoresis Instrument Enhances Benchtop Analysis
Aigenpulse’s Data Analysis Suite Automates Flow Cytometry
Recent Videos
Behind the Headlines episode 6
Drug Digest: Is Our Understanding of Stability Changing
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Behind the Headlines episode 5
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Circio and Certest to Collaborate on LNP Formulations

Feliza Mirasol
November 21st 2024
Article

The companies will collaborate to create and test circVec DNA–LNP formulations for use in potential therapeutic applications.

Drug Solutions Podcast: Dosage Forms: Roundtable on Oral Solid Dosage Trends

Drug Solutions Podcast: Dosage Forms: Roundtable on Oral Solid Dosage Trends

Patrick Lavery
October 30th 2024
Podcast

In this podcast episode, we discuss trends in dosage forms, specifically oral solid dosage, as viewed by five industry experts who recently exhibited at CPHI Milan.

Site Logo

Navigating Annex 1 for Early Phase Sterile Fill Finish in Clinical Supplies

Eurofins
November 21st 2024
Article

Stay compliant with Annex 1 for early phase sterile fill finish processes. Discover how to implement robust contamination control strategies, integrate isolator technology, and conduct integrity testing to meet stringent European Union standards. The guide provides a comprehensive look at key elements such as PUPSIT, critical zone controls, and monitoring and training for aseptic processes.

Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?

Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?

PDA
October 10th 2024
Podcast

Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.

Site Logo

Ensuring Quality from the Start: Raw Materials Testing Support

Eurofins
November 21st 2024
Article

Raw Materials are the foundation of every biopharma product. Our ultimate guide highlights how our testing support can help you establish purity, identity, and quality standards, ensuring a smooth manufacturing process and adherence to regulatory requirements.

Site Logo

Ensure the Safety of Allogeneic Therapies with Advanced qPCR Testing

Eurofins
November 21st 2024
Article

Elevate your viral screening with Eurofins BioPharma Product Testing’s qPCR- based assays. Our advanced testing goes beyond standard screenings to detect even dormant and hard-to-detect pathogens, ensuring comprehensive safety in every stage of the allogeneic therapy pipeline. Protect your products – and your patients- with industry-leading sensitivity and specificity.